Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods.

experimental models mesenchymal stromal cells multiple myeloma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Dec 2020
Historique:
received: 29 11 2020
revised: 20 12 2020
accepted: 21 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

Multiple myeloma is an incurable cancer formed by malignant plasma cells. For the proliferation and survival of myeloma cells, as well as the occurrence of the complications, numerous intra- and extra-cellular mechanisms are involved. The interaction of myeloma cells with the microenvironment is known to be one of the most critical mechanisms. A specific microenvironment could affect the progression and growth of tumor cells, as well as drug resistance. Among various microenvironment components, such as hematological and non-hematological cells, and soluble factors (cytokines, chemokines, and extracellular matrix (ECM) proteins), in this review, we focus on the role of mesenchymal cells. We aimed to summarize the experimental strategies used for conducting studies and current understanding of the biological roles in the pathogenesis of myeloma. Furthermore, we discuss the possible clinical applications targeting mesenchymal cells.

Identifiants

pubmed: 33374627
pii: cancers13010025
doi: 10.3390/cancers13010025
pmc: PMC7793501
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 19K08814

Références

Nat Rev Clin Oncol. 2017 Feb;14(2):100-113
pubmed: 27531699
Cell Death Dis. 2018 May 3;9(5):512
pubmed: 29724992
J Bone Miner Res. 2005 Dec;20(12):2254-63
pubmed: 16294278
Curr Opin Oncol. 2020 Mar;32(2):146-153
pubmed: 31833957
Leuk Lymphoma. 2007 Oct;48(10):2032-41
pubmed: 17917971
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31873722
Blood. 2009 Aug 27;114(9):1803-12
pubmed: 19597185
N Engl J Med. 2003 Dec 25;349(26):2483-94
pubmed: 14695408
Br J Haematol. 2019 Feb;184(4):578-593
pubmed: 30408155
Blood. 2012 Jul 19;120(3):e9-e16
pubmed: 22653974
Blood. 2014 Jun 26;123(26):4136-42
pubmed: 24833354
Br J Haematol. 2014 Jun;165(6):814-23
pubmed: 24650009
Haematologica. 2018 Dec;103(12):1945-1955
pubmed: 30337364
J Bone Miner Metab. 2009;27(1):16-23
pubmed: 19057841
Blood. 2008 Oct 1;112(7):2935-45
pubmed: 18535198
Leukemia. 2018 Jul;32(7):1500-1514
pubmed: 29535427
Cancer Lett. 2017 Sep 10;403:206-215
pubmed: 28645562
Br J Haematol. 2014 Nov;167(3):366-75
pubmed: 25139740
Exp Hematol. 2010 Feb;38(2):141-53
pubmed: 19963035
Cancer Res. 2012 Mar 15;72(6):1395-406
pubmed: 22301101
Leukemia. 2018 Aug;32(8):1739-1750
pubmed: 29925904
J Immunol. 1979 Feb;122(2):609-13
pubmed: 368243
Blood Adv. 2019 Nov 12;3(21):3228-3240
pubmed: 31698453
Clin Cancer Res. 2012 Jan 15;18(2):342-9
pubmed: 22065077
Stem Cells Dev. 2011 Apr;20(4):709-19
pubmed: 20695752
Immunity. 2004 Jun;20(6):707-18
pubmed: 15189736
Blood. 2008 Mar 1;111(5):2755-64
pubmed: 18180376
Eur J Cell Biol. 2019 Dec;98(5-8):151041
pubmed: 31023504
Cell Stem Cell. 2015 Mar 5;16(3):239-53
pubmed: 25748931
Blood. 2003 Apr 1;101(7):2775-83
pubmed: 12517814
Blood. 1997 Sep 15;90(6):2437-44
pubmed: 9310495
Oncotarget. 2014 Sep 30;5(18):8284-305
pubmed: 25268740
Blood. 2016 Apr 14;127(15):1896-906
pubmed: 26755711
Oncogene. 2009 Jan 15;28(2):231-42
pubmed: 18850009
Cancer Cell. 2018 Apr 9;33(4):634-648.e5
pubmed: 29551594
Mol Cancer Res. 2017 Apr;15(4):405-417
pubmed: 28119431
Nat Med. 2017 Dec;23(12):1436-1443
pubmed: 29106400
Nat Rev Immunol. 2006 Oct;6(10):741-50
pubmed: 16977339
Leukemia. 2015 May;29(5):1186-94
pubmed: 25388955
Blood. 1996 Feb 15;87(4):1495-501
pubmed: 8608240
J Clin Invest. 2013 Apr;123(4):1542-55
pubmed: 23454749
J Clin Invest. 2015 Oct 26;125(12):4375-90
pubmed: 26517694
Stem Cells. 2012 Feb;30(2):266-79
pubmed: 22102554
J Immunol. 2002 Aug 1;169(3):1277-82
pubmed: 12133949
Ann N Y Acad Sci. 2015 Jan;1335:32-44
pubmed: 25573321
PLoS One. 2010 Mar 25;5(3):e9870
pubmed: 20360846
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Blood. 2005 Jul 15;106(2):713-6
pubmed: 15817674
Br J Haematol. 2004 Aug;126(4):475-86
pubmed: 15287939
Nat Commun. 2018 Dec 3;9(1):4832
pubmed: 30510245
Mol Med Rep. 2017 Sep;16(3):2497-2504
pubmed: 28677723
Blood. 2005 Oct 1;106(7):2472-83
pubmed: 15933061
Blood Adv. 2017 Dec 19;1(27):2729-2741
pubmed: 29296925
N Engl J Med. 2004 Oct 28;351(18):1860-73
pubmed: 15509819
Leukemia. 2016 Jan;30(1):1-13
pubmed: 26108693
Br J Haematol. 2011 Nov;155(4):438-48
pubmed: 21923653
J Immunol. 2003 Feb 1;170(3):1136-40
pubmed: 12538668
Leukemia. 2017 Apr;31(4):997-1000
pubmed: 28074071
Am J Hematol. 2015 Jan;90(1):42-9
pubmed: 25294016
Bone. 2011 Jan;48(1):129-34
pubmed: 20570621
Blood. 2013 Apr 25;121(17):3413-9
pubmed: 23435460
Nat Rev Cancer. 2017 Aug 24;17(9):543-556
pubmed: 28835722
PLoS One. 2013 Nov 06;8(11):e79752
pubmed: 24223191
Cancer Cell. 2008 Feb;13(2):167-80
pubmed: 18242516
Oncogene. 2003 Apr 24;22(16):2417-21
pubmed: 12717418
J Immunol. 2012 Feb 1;188(3):1283-91
pubmed: 22262758
Blood. 2016 Dec 8;128(23):2599-2606
pubmed: 27737890
Cancer Cell. 2004 Feb;5(2):191-9
pubmed: 14998494
Semin Oncol. 2001 Dec;28(6):607-12
pubmed: 11740818
Nat Rev Mol Cell Biol. 2019 May;20(5):303-320
pubmed: 30745579
Haematologica. 2018 Jul;103(7):1218-1228
pubmed: 29622655
JCI Insight. 2017 Jul 6;2(13):
pubmed: 28679949
Leukemia. 2011 Apr;25(4):707-11
pubmed: 21233838
Nat Commun. 2015 Dec 03;6:8983
pubmed: 26632274
Blood. 2020 May 7;135(19):1650-1660
pubmed: 32076701
PLoS One. 2012;7(2):e30557
pubmed: 22347385
Eur J Haematol. 2013 Sep;91(3):196-200
pubmed: 23607294
Oncotarget. 2018 Apr 13;9(28):20119-20133
pubmed: 29732008
Blood. 2006 Dec 15;108(13):3992-6
pubmed: 16917004
J Immunol. 2008 Jan 1;180(1):361-71
pubmed: 18097037
Cancer. 2001 Apr 1;91(7):1219-30
pubmed: 11283920
Nature. 2016 Nov 10;539(7628):304-308
pubmed: 27783593
PLoS One. 2013 Nov 06;8(11):e79939
pubmed: 24223204
Immunity. 2016 Dec 20;45(6):1219-1231
pubmed: 27913094
Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):207-21
pubmed: 18512025
Nature. 2014 Feb 13;506(7487):240-4
pubmed: 24429522
Haematologica. 2020 Jan 31;105(2):457-467
pubmed: 31101754
BMC Cancer. 2015 Feb 18;15:68
pubmed: 25886144
J Clin Invest. 2017 Aug 1;127(8):3052-3064
pubmed: 28714866
Leukemia. 2017 Feb;31(2):373-381
pubmed: 27400413
Haematologica. 2007 Jun;92(6):803-11
pubmed: 17550853
Blood. 2007 Apr 1;109(7):3024-30
pubmed: 17138824
Blood Cells. 1978;4(1-2):7-25
pubmed: 747780
Leukemia. 2017 Dec;31(12):2661-2669
pubmed: 28487543
Leukemia. 2012 Sep;26(9):2135-41
pubmed: 22430638
Blood. 2009 Jul 9;114(2):371-9
pubmed: 19417213
J Immunol. 2010 Jul 1;185(1):302-12
pubmed: 20511548
Acta Pharmacol Sin. 2013 May;34(5):699-709
pubmed: 23564084
Mol Cancer Ther. 2010 Dec;9(12):3210-20
pubmed: 21159607
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Immunol Rev. 2018 May;283(1):86-98
pubmed: 29664564
Clin Cancer Res. 2012 Nov 15;18(22):6155-68
pubmed: 22988056
Cancer Res. 2012 May 1;72(9):2183-9
pubmed: 22374979
J Exp Med. 2004 Jan 5;199(1):91-8
pubmed: 14707116
J Biol Chem. 2017 Mar 10;292(10):4280-4292
pubmed: 28154173
Blood. 2013 Jan 10;121(2):318-28
pubmed: 23169779
Blood. 2011 May 12;117(19):5067-77
pubmed: 21415267
Stem Cell Reports. 2016 Aug 9;7(2):220-35
pubmed: 27453006
Nature. 2010 Apr 8;464(7290):852-7
pubmed: 20305640
Blood. 2011 Nov 24;118(22):5872-82
pubmed: 21908434
Curr Opin Oncol. 2020 Mar;32(2):154-161
pubmed: 32022758
Ann N Y Acad Sci. 2015 Sep;1351:114-26
pubmed: 26152292
Cancer Res. 2007 Aug 15;67(16):7665-74
pubmed: 17702698
Cell. 2019 Jun 13;177(7):1915-1932.e16
pubmed: 31130381
Immunol Rev. 2003 Aug;194:48-60
pubmed: 12846807
Blood. 2019 Jul 4;134(1):30-43
pubmed: 31023703
Dis Model Mech. 2012 Nov;5(6):763-71
pubmed: 23115205
Immunity. 2018 Apr 17;48(4):632-648
pubmed: 29669248
Blood. 1997 Jul 15;90(2):754-65
pubmed: 9226176
Br J Haematol. 2014 Oct;167(2):194-206
pubmed: 25079197
Cell Stem Cell. 2016 Nov 3;19(5):613-627
pubmed: 27666011
Blood. 1999 Mar 1;93(5):1658-67
pubmed: 10029595
JBMR Plus. 2019 Mar 15;3(3):e10183
pubmed: 30918921
Blood. 2005 Nov 1;106(9):3160-5
pubmed: 16030194
Clin Cancer Res. 2020 Jan 15;26(2):344-353
pubmed: 31672767
Am J Pathol. 2002 Apr;160(4):1293-9
pubmed: 11943714
Curr Opin Oncol. 2020 Mar;32(2):170-175
pubmed: 31895122
Adv Biochem Eng Biotechnol. 2013;129:1-17
pubmed: 22825720
Mol Carcinog. 2016 Dec;55(12):1927-1939
pubmed: 27023728
Cancer Cell. 2007 Apr;11(4):349-60
pubmed: 17418411
PLoS One. 2013;8(3):e59756
pubmed: 23555770
Nat Immunol. 2011 Feb;12(2):151-9
pubmed: 21217761
Nat Rev Immunol. 2017 Sep;17(9):573-590
pubmed: 28604734
Blood. 2009 Apr 30;113(18):4341-51
pubmed: 19139079
Eur J Immunol. 2014 Aug;44(8):2306-17
pubmed: 24777940
Immunol Rev. 2013 Jan;251(1):177-88
pubmed: 23278749
Blood. 2016 Jun 16;127(24):2955-62
pubmed: 27002115
Clin Cancer Res. 2019 Jul 1;25(13):3772-3775
pubmed: 30890552
Haematologica. 2020 Jun 05;105(9):e470-473
pubmed: 33054066
PLoS One. 2014 Mar 06;9(6):e90846
pubmed: 24603866
J Clin Oncol. 2007 May 20;25(15):1993-9
pubmed: 17420512
Nat Commun. 2019 Oct 4;10(1):4533
pubmed: 31586071
Nat Protoc. 2017 Oct;12(10):2169-2188
pubmed: 28933777
Arthritis Rheum. 2012 Aug;64(8):2632-43
pubmed: 22378497
Leukemia. 2009 Aug;23(8):1515-27
pubmed: 19357701
Blood. 1998 Oct 15;92(8):2908-13
pubmed: 9763577
Cell Stem Cell. 2018 Jan 4;22(1):64-77.e6
pubmed: 29276143
Cancer Res. 2011 Jan 15;71(2):339-48
pubmed: 21224354
Blood. 2012 Jun 14;119(24):5782-94
pubmed: 22394600
Nat Rev Clin Oncol. 2018 Apr;15(4):219-233
pubmed: 29311715
Curr Opin Hematol. 2016 Jul;23(4):331-8
pubmed: 27177311
Ann N Y Acad Sci. 2011 Nov;1237:19-23
pubmed: 22082361
Stem Cells Dev. 2010 Sep;19(9):1289-96
pubmed: 20121456
Leukemia. 2004 Nov;18(11):1891-7
pubmed: 15385929
Nat Med. 2016 Nov;22(11):1351-1357
pubmed: 27723723
Leukemia. 2007 Jan;21(1):158-63
pubmed: 17096013
Int J Hematol. 2016 Sep;104(3):281-92
pubmed: 27411688
Blood. 2011 Dec 22;118(26):6871-80
pubmed: 22042697
Bone. 2011 May 1;48(5):1117-26
pubmed: 21255693
Blood. 2008 Jul 1;112(1):159-68
pubmed: 18436739
Nat Cell Biol. 2017 Jun;19(6):677-688
pubmed: 28481328
Blood. 2019 Apr 4;133(14):1534-1539
pubmed: 30760454
Leukemia. 2007 May;21(5):1079-88
pubmed: 17344918
Leukemia. 2007 Oct;21(10):2181-91
pubmed: 17657224
J Cell Biochem. 2005 Oct 15;96(3):533-42
pubmed: 16088945
Haematologica. 2015 Jun;100(6):834-841
pubmed: 25715406
Leuk Lymphoma. 2001 Apr;41(3-4):239-45
pubmed: 11378537
Stem Cell Reports. 2013 Jul 11;1(2):152-65
pubmed: 24052950
Am J Pathol. 1988 Sep;132(3):593-7
pubmed: 3414786
Nat Med. 2013 Nov;19(11):1513-7
pubmed: 24162813
Sci Rep. 2019 Jan 31;9(1):1056
pubmed: 30705326
Blood. 2007 Jul 1;110(1):334-8
pubmed: 17371942

Auteurs

Michiko Ichii (M)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka 5650871, Japan.

Naoki Hosen (N)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka 5650871, Japan.

Classifications MeSH